| The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic … H Ghebeh, S Mohammed, A Al-Omair, A Qattant, C Lehe, G Al-Qudaihi, ... Neoplasia 8 (3), 190-198, 2006 | 727 | 2006 |
| Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells J Molldrem, S Dermime, K Parker, YZ Jiang, D Mavroudis, N Hensel, ... | 427 | 1996 |
| NY-ESO-1 based immunotherapy of cancer: current perspectives R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, ... Frontiers in immunology 9, 947, 2018 | 395 | 2018 |
| Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Q Fernandes, VP Inchakalody, M Merhi, S Mestiri, N Taib, ... Annals of medicine 54 (1), 524-540, 2022 | 383 | 2022 |
| FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy H Ghebeh, E Barhoush, A Tulbah, N Elkum, T Al-Tweigeri, S Dermime BMC cancer 8, 1-12, 2008 | 287 | 2008 |
| Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule H Ghebeh, C Lehe, E Barhoush, K Al-Romaih, A Tulbah, M Al-Alwan, ... Breast Cancer Research 12, 1-12, 2010 | 261 | 2010 |
| Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges K Sivaraman Siveen, K Prabhu, R Krishnankutty, S Kuttikrishnan, ... Current vascular pharmacology 15 (4), 339-351, 2017 | 213 | 2017 |
| Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation R Ahmad, A Al-Mass, V Atizado, A Al-Hubail, F Al-Ghimlas, M Al-Arouj, ... Journal of inflammation 9, 1-11, 2012 | 192 | 2012 |
| A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation W Shao, L Benedetti, WW Lamph, C Nervi, WH Miller Jr Blood, The Journal of the American Society of Hematology 89 (12), 4282-4289, 1997 | 187 | 1997 |
| Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells H Ghebeh, A Tulbah, S Mohammed, N ElKum, SMB Amer, T Al‐Tweigeri, ... International journal of cancer 121 (4), 751-758, 2007 | 185 | 2007 |
| RAS-mediated oncogenic signaling pathways in human malignancies AQ Khan, S Kuttikrishnan, KS Siveen, KS Prabhu, M Shanmugakonar, ... Seminars in cancer biology 54, 1-13, 2019 | 172 | 2019 |
| Breast carcinoma–associated fibroblasts and their counterparts display neoplastic-specific changes NM Hawsawi, H Ghebeh, SF Hendrayani, A Tulbah, M Al-Eid, ... Cancer research 68 (8), 2717-2725, 2008 | 168 | 2008 |
| Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience N Elkum, S Dermime, D Ajarim, A Al-Zahrani, A Alsayed, A Tulbah, ... BMC cancer 7, 1-8, 2007 | 146 | 2007 |
| Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation S Dermime, D Mavroudis, YZ Jiang, N Hensel, J Molldrem, AJ Barrett Bone marrow transplantation 19 (10), 989-999, 1997 | 143 | 1997 |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances KM Maalej, M Merhi, VP Inchakalody, S Mestiri, M Alam, C Maccalli, ... Molecular Cancer 22 (1), 20, 2023 | 139 | 2023 |
| Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products KS Siveen, KS Prabhu, IW Achkar, S Kuttikrishnan, S Shyam, AQ Khan, ... Molecular cancer 17, 1-21, 2018 | 136 | 2018 |
| The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized … Y Xu, B Wan, X Chen, P Zhan, Y Zhao, T Zhang, H Liu, MZ Afzal, ... Translational Lung Cancer Research 8 (4), 413, 2019 | 124 | 2019 |
| The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone S Dermime, S Afreen Hematology/oncology and stem cell therapy 7 (1), 1-17, 2014 | 122 | 2014 |
| Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RARα protein S Dermime, F Grignani, M Clerici, C Nervi, G Sozzi, GP Talamo, ... Blood 82 (5), 1573-1577, 1993 | 118 | 1993 |
| Cancer vaccines and immunotherapy S Dermime, A Armstrong, RE Hawkins, PL Stern British medical bulletin 62 (1), 149-162, 2002 | 112 | 2002 |
Shahab Uddin, PhDPrincipal Research Scientist & Professor of Cancer Biology Hamad Medical Corporation在 hamad.qa 的电子邮件经过验证
